Synthesis of compounds with potential biomedical activity: SARS-CoV-2 main protease inhibitors and ABA analogs
Metadades
Mostra el registre complet de l'elementcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/29747
comunitat-uji-handle3:10234/162741
comunitat-uji-handle4:
TESISMetadades
Títol
Synthesis of compounds with potential biomedical activity: SARS-CoV-2 main protease inhibitors and ABA analogsAutoria
Director/a
González, FlorenciPrograma de Doctorat
Programa de Doctorat en CiènciesÒrgan responsable
Universitat Jaume I. Escola de DoctoratData de defensa
2024-04-17Editor
Universitat Jaume IParaules clau
Àrea de coneixement
Pàgines
313 p.Resum
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has increased the development of new antiviral drugs to stop its spread. This work focused on synthesizing specific inhibitors of the Mpro protease, crucial for ... [+]
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has increased the development of new antiviral drugs to stop its spread. This work focused on synthesizing specific inhibitors of the Mpro protease, crucial for the virus replication. Compounds with a nitroalkene-type "warhead" were synthesized, showing promising inhibitory activity against this enzyme. Additionally, inhibitors with a keto vinyl sulfone-type "warhead" were synthesized, showing variable inhibition trends against Mpro, CatL, and rhodesain. Furthermore, an ABA antagonist was synthesized, delaying shoot development and fruit generation, offering potential improvements in crop yield. Lastly, fluorescent derivatives of ABA were synthesized, shedding light on its cellular mechanisms. These findings contribute to the development of antiviral drugs and highlight the diverse roles of ABA beyond plants, potentially benefiting human health. [-]
Drets d'accés
L'accés als continguts d'aquesta tesi queda condicionat a l'acceptació de les condicions d'ús establertes per la següent llicència Creative Commons: http://creativecommons.org/licenses/by-sa/4.0/
info:eu-repo/semantics/embargoedAccess
info:eu-repo/semantics/embargoedAccess